Acute rejection (AR) is common during the first year after lung transplantation (LuTx) and can trigger chronic rejection (CR), the leading cause of late morbidity and mortality of LuTx. Extracorporeal photopheresis (ECP) is a promising treatment for chronic rejection. Few studies focus on ECP as prophylactic therapy of AR and CR. Microvesicles and exosomes (i.e.extracellular vesicles EV) are released into the blood and in bronchoalveolar lavage (BAL) and their role in cell-to-cell communication has been assessed in several studies; EV have been proposed as non-invasive biomarkers to assess lung injury and monitor clinical outcome.
Surface antigens on plama extracellular vescicles of cystic fibrosis patients treated by extracorporeal photopheresis as induction therapy after lung transplantation: preliminary results of a pilot randomizd trial / L. Rosso, I. Righi, M. Barilani, G. Buono, F. Damarco, D. Trabattoni, C. Diotti, M. Cattaneo, M. Nosotti, C. Mocellin, L. Lazzari. - In: THE JOURNAL OF HEART AND LUNG TRANSPLANTATION. - ISSN 1053-2498. - 39:4S(2020 Apr), pp. S358-S358. ((Intervento presentato al convegno ISHLT 2020 Annual Meeting nel 2020.
|Titolo:||Surface antigens on plama extracellular vescicles of cystic fibrosis patients treated by extracorporeal photopheresis as induction therapy after lung transplantation: preliminary results of a pilot randomizd trial|
ROSSO, LORENZO PAOLO ANTONIO (Primo)
|Settore Scientifico Disciplinare:||Settore MED/21 - Chirurgia Toracica|
Settore MED/04 - Patologia Generale
|Data di pubblicazione:||apr-2020|
|Appare nelle tipologie:||01 - Articolo su periodico|
File in questo prodotto:
|ISHLT 2020 JHLT (Surface antigens on plasma...).pdf||Publisher's version/PDF||Administrator Richiedi una copia|